GORE launches TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System
In May 2019, Gore announced FDA approval of the TAG® Conformable Thoracic Stent Graft with active control system for treatment of aneurysms, transections and type B dissections of the descending thoracic aorta. Although no changes were made to the endograft itself, the active control system delivers a two-stage deployment that allows for added precision in endograft placement and continuous blood flow during the procedure. This device has already been successfully used in a TEVAR procedure. To read more, click the link below:
https://evtoday.com/2019/07/10/gores-tag-conformable-thoracic-stent-graft-with-active-control-system-launched-in-the-united-states?center=13
